Management of Cancer-Associated Myositis

PURPOSE OF THE REVIEW: Cancer-associated myositis (CAM) is defined as when cancer appears within 3 years of myositis onset. Dermatomyositis and seronegative immune–mediated necrotizing myopathy are the phenotypes mostly related to cancer. In general, treatment principles in myositis patients with an...

Descripción completa

Detalles Bibliográficos
Autores principales: Selva-O’Callaghan, Albert, Trallero-Araguás, Ernesto, Ros, Javier, Gil-Vila, Albert, Lostes, Julia, Agustí, Antonia, Riera-Arnau, Judit, Alvarado-Cárdenas, Marcelo, Pinal-Fernandez, Iago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Other CTD: Inflammatory Myopathies and Sjogren's (I Pinal-Fernández, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589595/
https://www.ncbi.nlm.nih.gov/pubmed/36313478
http://dx.doi.org/10.1007/s40674-022-00197-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589595/
https://www.ncbi.nlm.nih.gov/pubmed/36313478
http://dx.doi.org/10.1007/s40674-022-00197-2

Ejemplares similares